https://www.marketscreener.com/quote/stock/LANTHEUS-HOLDINGS-INC-17053982/news/Lantheus-Holdings-Inc-Announces-First-Patient-Dosed-in-Phase-2-Clinical-Trial-of-NM-01-to-Monitor-40434425/?utm_source=telegram&utm_medium=social&utm_campaign=share